वैकल्पिक उत्पाद विश्लेषण
आपकी अनुमति से हम गोपनीयता-सीमित विश्लेषण का उपयोग करके समझते हैं कि कौन-सी शोध यात्राएँ उपयोगी हैं। हम विज्ञापन ट्रैकर या सत्र रिकॉर्डिंग नहीं चलाते। आप यह विकल्प प्राथमिकताओं में बदल सकते हैं। पढ़ें गोपनीयता नीति.
Moderna Inc.'s published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $21.1B |
|---|
| Revenue (ttm) | 2.2B |
|---|
| Net income (ttm) | -3.2B |
|---|
| EPS (ttm) | -$8.01 |
|---|
| Shares out | 399.2M |
|---|
| Volume | 10,987,308 |
|---|
| Beta | 1.09 |
|---|
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $17.74B | $18.88B | $6.75B | $3.20B | $1.92B | -42.6% |
| Gross profit | $15.12B | $13.46B | $2.06B | $1.74B | $1.05B | -48.6% |
| Operating income | $13.30B | $9.42B | $-4.24B | $-3.58B | $-2.76B | — |
| Net income | $12.20B | $8.36B | $-4.71B | $-3.56B | $-2.82B | — |
| EPS (diluted) | $28.29 | $20.12 | $-12.33 | $-9.28 | — | — |
| EBITDA | $13.53B | $9.77B | $-3.62B | $-3.39B | $-2.54B | — |
| R&D | $1.99B | $3.30B | $4.85B | $4.54B | $3.13B | +12.0% |
| SG&A | $567.0M | $1.13B | $1.55B | $1.17B | $1.02B | +15.8% |
Recent company headlines from major financial publishers.
The mRNA platform's speed and adaptability result in best-in-class efficacy for multiple latent virus and oncology targets. MRNA establishes a broad, highly profitable commercial portfolio, driving revenues back toward $10B+ with 70%+ gross margins and substantial operating leverage.
Moderna undergoes a high-risk transition, absorbing multi-billion dollar operating losses to sustain its $3.1B R&D engine. The validated mRNA platform produces sufficient new blockbusters to return to revenue growth and reach steady-state profitability by the end of the decade.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 7.5% | $68.8 | $75.7 | $84.0 | $94.5 | $102 |
| 8.5% | $58.3 | $63.1 | $68.8 | $75.7 | $84.0 |
| 9.5% | $50.6 | $54.2 | $58.3 | $63.1 | $68.8 |
| 10.5% | $44.6 | $47.4 | $50.6 | $54.2 | $58.3 |
| 11.5% | $40.0 | $42.2 | $44.6 | $47.4 | $50.6 |
Upcoming earnings date and setup when available.
हर महीने प्रकाशित शोध संस्करण की रेटिंग। रेटिंग विश्लेषण की तारीख की कीमत की तुलना उचित मूल्य से करती है; यह इस बात का रिकॉर्ड नहीं है कि आकलन सही निकला या नहीं।
| वर्ष | जन॰ | फ़र॰ | मार्च | अप्रैल | मई | जून | जुल॰ | अग॰ | सित॰ | अक्टू॰ | नव॰ | दिस॰ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
